LifeLoc Technologies Inc (LCTC)

[pdicamillo1]

Quartely earnings are out. Lifeloc posted a profitable quarter: $.02/share.

More importantly we heard from Charles Gonzales, Research and Development Manager, who said,
"We have moved into the next critical phase of the SpinDx product development cycle, now developing our custom microfluidic disk with the first targeted drug being cannabis. We have also added tests for cocaine and amphetamines and have initiated work to detect fentanyl for our subsequent drug panel. The project is maintaining good momentum. We continue with validation testing utilizing actual human samples obtained through the Colorado School of Public Health at the University of Colorado Anschutz, with results to date confirming SpinDx performance."